Therefore, in this study, using FISH, we analyzed the copy number alterations of five genes (HER2, MDM2, c-MYC, c-MET, and TP53) in the CTC obtained from GC patients to evaluate their usage as a potential complement approach for primary tumor biopsies. This evidence concerns the gene MYC and neoplasm.